Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ

Peroxisome proliferator-activated receptors (PPARs) are a class of transcription factors that belong to the nuclear hormone receptor superfamily, and their activities are dependent on their respective ligands. Since the discovery of PPARα (NR1C1) as a receptor that mediates peroxisome proliferation...

Full description

Saved in:
Bibliographic Details
Main Authors: Tan, Nguan Soon, Vázquez-Carrera, Manuel, Montagner, Alexandra, Sng, Ming Keat, Guillou, Hervé, Wahli, Walter
Other Authors: School of Biological Sciences
Format: Article
Language:English
Published: 2017
Subjects:
Online Access:https://hdl.handle.net/10356/83576
http://hdl.handle.net/10220/42710
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-83576
record_format dspace
spelling sg-ntu-dr.10356-835762020-11-01T05:19:03Z Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ Tan, Nguan Soon Vázquez-Carrera, Manuel Montagner, Alexandra Sng, Ming Keat Guillou, Hervé Wahli, Walter School of Biological Sciences Lee Kong Chian School of Medicine (LKCMedicine) Peroxisome Proliferator-Activated Receptors Transcription Peroxisome proliferator-activated receptors (PPARs) are a class of transcription factors that belong to the nuclear hormone receptor superfamily, and their activities are dependent on their respective ligands. Since the discovery of PPARα (NR1C1) as a receptor that mediates peroxisome proliferation in rodent hepatocytes in 1990 [1], two other isotypes, PPARβ/δ (NR1C2) and PPARγ (NR1C3), were subsequently identified and characterized [2,3]. Members of the PPAR family have been extensively linked to numerous systemic and cellular activities that range far beyond simply mediating peroxisome proliferation in rodents [4]. Dependent on isotype-specific or shared tissue expression, all three PPARs regulate different or, in some cases, overlapping functions [5]. PPARα and PPARγ have established roles in fatty acid (FA) catabolism and in adipocyte differentiation and lipid storage, respectively, and both are pharmacological targets of FDA-approved drugs for the treatment of numerous metabolic diseases [6,7]. In contrast, no PPARβ/δ ligands are currently used in the treatment of any disease, although small studies on human subjects have used PPARβ/δ ligands to treat metabolic syndrome [8,9]. PPARβ/δ is expressed in numerous tissues [10,11], and many important functions have been attributed to PPARβ/δ in skeletal muscle, adipose tissue, the cardiovascular system, uterine implantation, the gut, the brain, and skin [12]. These factors make PPARβ/δ a very attractive and challenging target, as it is involved in numerous key functions, such as energy metabolism, cellular differentiation and proliferation, tissue repair, and cancer progression. ASTAR (Agency for Sci., Tech. and Research, S’pore) MOE (Min. of Education, S’pore) NMRC (Natl Medical Research Council, S’pore) MOH (Min. of Health, S’pore) Accepted version 2017-06-15T06:27:37Z 2019-12-06T15:25:58Z 2017-06-15T06:27:37Z 2019-12-06T15:25:58Z 2016 Journal Article Tan, N. S., Vázquez-Carrera, M., Montagner, A., Sng, M. K., Guillou, H., & Wahli, W. (2016). Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ. Progress in Lipid Research, 64, 98-122. 0163-7827 https://hdl.handle.net/10356/83576 http://hdl.handle.net/10220/42710 10.1016/j.plipres.2016.09.001 en Progress in Lipid Research © 2016 Elsevier Ltd. This is the author created version of a work that has been peer reviewed and accepted for publication by Progress in Lipid Research, Elsevier Ltd. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1016/j.plipres.2016.09.001]. 121 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Peroxisome Proliferator-Activated Receptors
Transcription
spellingShingle Peroxisome Proliferator-Activated Receptors
Transcription
Tan, Nguan Soon
Vázquez-Carrera, Manuel
Montagner, Alexandra
Sng, Ming Keat
Guillou, Hervé
Wahli, Walter
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
description Peroxisome proliferator-activated receptors (PPARs) are a class of transcription factors that belong to the nuclear hormone receptor superfamily, and their activities are dependent on their respective ligands. Since the discovery of PPARα (NR1C1) as a receptor that mediates peroxisome proliferation in rodent hepatocytes in 1990 [1], two other isotypes, PPARβ/δ (NR1C2) and PPARγ (NR1C3), were subsequently identified and characterized [2,3]. Members of the PPAR family have been extensively linked to numerous systemic and cellular activities that range far beyond simply mediating peroxisome proliferation in rodents [4]. Dependent on isotype-specific or shared tissue expression, all three PPARs regulate different or, in some cases, overlapping functions [5]. PPARα and PPARγ have established roles in fatty acid (FA) catabolism and in adipocyte differentiation and lipid storage, respectively, and both are pharmacological targets of FDA-approved drugs for the treatment of numerous metabolic diseases [6,7]. In contrast, no PPARβ/δ ligands are currently used in the treatment of any disease, although small studies on human subjects have used PPARβ/δ ligands to treat metabolic syndrome [8,9]. PPARβ/δ is expressed in numerous tissues [10,11], and many important functions have been attributed to PPARβ/δ in skeletal muscle, adipose tissue, the cardiovascular system, uterine implantation, the gut, the brain, and skin [12]. These factors make PPARβ/δ a very attractive and challenging target, as it is involved in numerous key functions, such as energy metabolism, cellular differentiation and proliferation, tissue repair, and cancer progression.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Tan, Nguan Soon
Vázquez-Carrera, Manuel
Montagner, Alexandra
Sng, Ming Keat
Guillou, Hervé
Wahli, Walter
format Article
author Tan, Nguan Soon
Vázquez-Carrera, Manuel
Montagner, Alexandra
Sng, Ming Keat
Guillou, Hervé
Wahli, Walter
author_sort Tan, Nguan Soon
title Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
title_short Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
title_full Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
title_fullStr Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
title_full_unstemmed Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
title_sort transcriptional control of physiological and pathological processes by the nuclear receptor pparβ/δ
publishDate 2017
url https://hdl.handle.net/10356/83576
http://hdl.handle.net/10220/42710
_version_ 1683493601795899392